Medical and Pharmaceutical Soleno Therapeutics pulls in FDA nod for treatment for rare genetic disease This approval is a hard-won victory for Soleno after a lengthy clinical trial phase Joseph MortonMarch 27, 2025
AI and Autonomy Median Technologies and European Investment Bank agrees to €37.5M loan The tech leverages machine learning to analyze imaging data generated by low-dose computed tomography Joseph MortonJanuary 28, 2025
Health & Wellness Breath Diagnostics onboards new president and closes critical financing Aaron Roebuck brings three decades of experience in respiratory and cardiopulmonary medicine, and commercialization of medical devices Joseph MortonOctober 31, 2024
Medical and Pharmaceutical Scholar Rock stock skyrockets on successful phase 3 trial results The SAPPHIRE study demonstrated statistically significant and clinically meaningful improvements Joseph MortonOctober 7, 2024
Health & Wellness Breath Diagnostics takes aim at lung cancer with One Breath Early detection is crucial in improving survival rates and the chances of successful treatment for lung cancer Joseph MortonAugust 26, 2024
Psychedelics FDA publishes first draft guidance document for psychedelics research It aims to highlight relevant considerations for researchers investigating the therapeutic value of psychedelics Rowan DunneJune 23, 2023
Health and Safety FDA to reject medical device applications without cyberattack protection plans As many as 40 per cent of end-of-life devices have no protection at all against cyberattacks Joseph MortonMarch 31, 2023
Technology Inspira Technologies seeks FDA approval for cardiopulmonary device The ALICE incorporates several of Inspira's features and capabilities into one handy device Joseph MortonDecember 20, 2022
Sleep Inspire Medical Systems recruits top tier investor relations talent Yagci brings over 15 years experience as an institutional investor in medical devices and healthcare services to the table. Joseph MortonAugust 22, 2022
Business MediPharm Labs to enter US pharmaceutical market via FDA drug registration If approved, it could advance the firm's goal of becoming a dominant supplier of cannabinoid pharmaceutical ingredients Natalia Buendia CalvilloFebruary 23, 2022